Treatment Continuity Act of 2025
A BILL
To amend the Public Health Service Act to authorize the Secretary of Health and Human Services to address priority substance use disorder and serious mental illness treatment needs through long-acting injectable medications, and for other purposes.
Sec. 2 Priority substance use disorder and serious mental illness treatment needs of regional and national significance
“(1) access to long-acting injectable medications that are approved by the Food and Drug Administration for the treatment of individuals with substance use disorders or serious mental illness;
“(2) lab testing and supportive counseling for substance use disorder and serious mental illness; and
“(3) training on the use of long-acting injectable medications for the purposes described in paragraph (1), in combination with associated clinical services such as counseling.”
“(d) Annual report to Congress—Not later than 1 year after the date of enactment of the Treatment Continuity Act of 2025, and annually thereafter during the term of the program under this section, the Secretary shall transmit to Congress a report on the outcomes of such program, including completed or substantial progress toward treatment requirements based on clinician assessment.”